Agilent Technologies Inc (A) Announces $0.15 Quarterly Dividend
Agilent Technologies Inc (NYSE:A) announced a quarterly dividend on Wednesday, September 19th, RTT News reports. Investors of record on Tuesday, October 2nd will be given a dividend of 0.149 per share by the medical research company on Wednesday, October 24th. This represents a $0.60 annualized dividend and a yield of 0.86%.
Agilent Technologies has a dividend payout ratio of 22.1% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Agilent Technologies to earn $2.98 per share next year, which means the company should continue to be able to cover its $0.60 annual dividend with an expected future payout ratio of 20.1%.
Agilent Technologies stock traded up $0.65 during midday trading on Wednesday, hitting $69.58. 87,989 shares of the company were exchanged, compared to its average volume of 2,535,450. The firm has a market cap of $21.95 billion, a price-to-earnings ratio of 29.27, a price-to-earnings-growth ratio of 2.36 and a beta of 1.36. Agilent Technologies has a fifty-two week low of $60.42 and a fifty-two week high of $75.00. The company has a quick ratio of 3.00, a current ratio of 3.62 and a debt-to-equity ratio of 0.39.
In other Agilent Technologies news, Director Paul N. Clark sold 2,876 shares of the firm’s stock in a transaction on Thursday, September 13th. The stock was sold at an average price of $68.60, for a total transaction of $197,293.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Heidi Fields sold 5,482 shares of the firm’s stock in a transaction on Tuesday, September 11th. The stock was sold at an average price of $67.73, for a total value of $371,295.86. The disclosure for this sale can be found here.
A has been the topic of a number of recent analyst reports. ValuEngine upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Wednesday, July 25th. Morgan Stanley increased their price target on Agilent Technologies from $83.00 to $84.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 15th. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price target on the stock in a research report on Tuesday, August 7th. Goldman Sachs Group reiterated a “buy” rating and set a $82.00 price target (up previously from $77.00) on shares of Agilent Technologies in a research report on Tuesday. Finally, Deutsche Bank increased their price target on Agilent Technologies from $77.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, August 15th. Ten research analysts have rated the stock with a buy rating, The stock presently has a consensus rating of “Buy” and an average target price of $77.22.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Read More: Stock Symbol
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.